Simone L. Holmes-Ardern

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke.

Eligibility for Thrombolysis for Pediatric Acute Ischemic Stroke.

Journal: Stroke

Published: August 27, 2026

Development and Adaptive Function in Individuals With SCN2A-Related Disorders.

Development and Adaptive Function in Individuals With SCN2A-Related Disorders.

Journal: Neurology

Published: July 22, 2025

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy.

Journal: Epilepsia

Published: June 17, 2025

'Fighting every day': exploring caregiver quality of life and perspectives on healthcare services for children with dementia - a cross-sectional, mixed-methods study.

'Fighting every day': exploring caregiver quality of life and perspectives on healthcare services for children with dementia - a cross-sectional, mixed-methods study.

Journal: Archives of disease in childhood

Published: September 17, 2024

Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers.

Characterizing Common Phenotypes Across the Childhood Dementia Disorders: A Cross-sectional Study From Two Australian Centers.

Journal: Pediatric neurology

Published: June 07, 2023

CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes.

CSF neopterin and quinolinic acid are biomarkers of neuroinflammation and neurotoxicity in FIRES and other infection-triggered encephalopathy syndromes.

Journal: Annals of clinical and translational neurology

Published: May 02, 2023

CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation.

CSF neopterin, quinolinic acid and kynurenine/tryptophan ratio are biomarkers of active neuroinflammation.

Journal: EBioMedicine

Published: January 08, 2023

GABRA1-Related Disorders: From Genetic to Functional Pathways.

GABRA1-Related Disorders: From Genetic to Functional Pathways.

Journal: Annals of neurology

Published: December 08, 2022

Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.

Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids.

Journal: EBioMedicine

Published: June 24, 2022

Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

Journal: Communications biology

Published: October 29, 2021

Surgical Treatment for SWS Glaucoma: Experience From a Tertiary Referral Pediatric Hospital.

Surgical Treatment for SWS Glaucoma: Experience From a Tertiary Referral Pediatric Hospital.

Journal: Journal of glaucoma

Published: August 28, 2020

Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study.

Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study.

Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus

Published: April 09, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026